Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease

BACKGROUND: Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma cruzi (T. cruzi) that affects more than 6 million people, mainly in Latin America. Benznidazole is still the drug of choice in many countries to treat it in spite of its dosage regimen and adverse side...

Descripción completa

Detalles Bibliográficos
Autores principales: Rial, Marcela S., Scalise, María L., Arrúa, Eva C., Esteva, Mónica I., Salomon, Claudio J., Fichera, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755931/
https://www.ncbi.nlm.nih.gov/pubmed/29267280
http://dx.doi.org/10.1371/journal.pntd.0006119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755931/
https://www.ncbi.nlm.nih.gov/pubmed/29267280
http://dx.doi.org/10.1371/journal.pntd.0006119

Ejemplares similares